82 related articles for article (PubMed ID: 426139)
1. Depression: new evidence in support of biological differentiation.
Garfinkel PE; Warsh JJ; Stancer HC
Am J Psychiatry; 1979 Apr; 136(4B):535-9. PubMed ID: 426139
[TBL] [Abstract][Full Text] [Related]
2. CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor.
Garfinkel PE; Warsh JJ; Stancer HC; Godse DD
Arch Gen Psychiatry; 1977 Jun; 34(6):735-9. PubMed ID: 869670
[TBL] [Abstract][Full Text] [Related]
3. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.
Amamoto T; Sarai K
Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369
[No Abstract] [Full Text] [Related]
4. [Changes in urinary levels of MHPG, VMA and 5-HIAA and plasma tryptophan in post-partum blues. Initial results].
Garnier JP; Bousquet B; Dreux C; Rouillon F; Lepine JP; Lemperiere T
Encephale; 1985; 11(1):35-7. PubMed ID: 2581764
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
6. The effect of a peripheral decarboxylase inhibitor (carbidopa) on monoamine and neuroendocrine function in man.
Garfinkel PE; Warsh JJ; Stancer HC; Godse DD; Brown GM; Vranic M
Neurology; 1977 May; 27(5):443-7. PubMed ID: 558549
[TBL] [Abstract][Full Text] [Related]
7. [Urinary excretion of 5-hydroxyindoleacetic acid and serum tryptophan and serotonin levels in patients with depression].
Pietruszewska I; Jasińska M; Lewicka-Wysocka H; Marcjan K; Stencka K
Psychiatr Pol; 1984; 18(1):9-16. PubMed ID: 6204348
[No Abstract] [Full Text] [Related]
8. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
11. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
Grossman F; Potter WZ
Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
[TBL] [Abstract][Full Text] [Related]
12. The indoleamine hypothesis of depression: an overview and pilot study.
Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
[TBL] [Abstract][Full Text] [Related]
13. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
Dakhlaoui O; Essafi I; Haffani F
Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
[TBL] [Abstract][Full Text] [Related]
14. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
Smith DJ; Muir WJ; Blackwood DH
J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232
[TBL] [Abstract][Full Text] [Related]
15. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone catecholamines in affective disease.
Garver DL; Pandey GN; Dekirmenjian H; Deleon-Jones F
Am J Psychiatry; 1975 Nov; 132(11):1149-54. PubMed ID: 1166891
[TBL] [Abstract][Full Text] [Related]
17. [Joint evolution of erythrocyte membrane transport of tyrosine and tryptophan as a function of the clinical course of depression].
Bovier P; Pringuey D; Widmer J; Chiaroni P; Gaillard JM; Dufour H; Tissot R
Encephale; 1988; 14(1):19-26. PubMed ID: 3371249
[TBL] [Abstract][Full Text] [Related]
18. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
[TBL] [Abstract][Full Text] [Related]
19. Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.
Sato T; Bottlender R; Sievers M; Möller HJ
J Affect Disord; 2006 Jan; 90(1):1-5. PubMed ID: 16325920
[TBL] [Abstract][Full Text] [Related]
20. Types of depression more frequent in bipolar than in unipolar affective illness: results of the Polish DEP-BI study.
Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
Psychopathology; 2007; 40(3):153-8. PubMed ID: 17318007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
